Cargando…
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor survival. The incidence and mortality of IPF are rising, but treatment remains limited. Currently, two drugs can slow the scarring process but often at the expense of intolerable side effects, and without sub...
Autores principales: | May, James, Mitchell, Jane A., Jenkins, R. Gisli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503802/ https://www.ncbi.nlm.nih.gov/pubmed/37712420 http://dx.doi.org/10.1172/JCI172058 |
Ejemplares similares
-
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
por: John, Alison E., et al.
Publicado: (2021) -
Goldilocks and the Three Trials: Clinical Trials Targeting the α(v)β(6) Integrin in Idiopathic Pulmonary Fibrosis
por: Sime, Patricia, et al.
Publicado: (2022) -
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022) -
The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
por: Zhu, Jiahui, et al.
Publicado: (2022) -
Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Salton, Francesco, et al.
Publicado: (2019)